Companies: 10,795·Total market cap: $144.5T
Castle Biosciences, Inc.

Castle Biosciences, Inc.

CSTLNASDAQHealthcare● Active
$20.12
$-0.89(-4.24%)
Market Cap$610238634
P/E Ratio
52W High$44.28
52W Low$14.59

Castle Biosciences, Inc. (CSTL) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · CSTL · as of Jun 8, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

83

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Castle Biosciences, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

CSTL insider buying and selling by quarter

CSTL insider selling · CSTL insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
581K290K0
2025 Q3
2025 Q4
2026 Q1
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · CSTL ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

CSTL executive sell shares · CSTL board member insider trading · CSTL insider trading SEC filing

Showing 68 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Cole G Bradley

Director

Option

Date

May 22

Shares

13,667

Price

Value

View Form 4 on SEC.gov

BRADBURY DANIEL

Director

Option

Date

May 22

Shares

13,667

Price

Value

View Form 4 on SEC.gov

Harrison Miles

Director

Option

Date

May 22

Shares

13,667

Price

Value

View Form 4 on SEC.gov

Olson Tiffany

Director

Option

Date

May 22

Shares

13,667

Price

Value

View Form 4 on SEC.gov

Goldberg Ellen

Director

Option

Date

May 22

Shares

13,667

Price

Value

View Form 4 on SEC.gov

Caple Kim

Director

Option

Date

May 22

Shares

13,667

Price

Value

View Form 4 on SEC.gov

Cotton Rodney

Director

Option

Date

May 22

Shares

13,667

Price

Value

View Form 4 on SEC.gov

Juvenal Tobin W

Chief Commercial Officer

Option

Date

May 21

Shares

11,210

Price

$3.38

Value

$38K

View Form 4 on SEC.gov

MAETZOLD DEREK J

Pres. & Chief Exec. Officer · Director

Sale

Date

May 20

Shares

322

Price

$20.00

Value

$6K

View Form 4 on SEC.gov

MAETZOLD DEREK J

Pres. & Chief Exec. Officer · Director

Sale

Date

May 21

Shares

1,035

Price

$20.20

Value

$21K

View Form 4 on SEC.gov

MAETZOLD DEREK J

Pres. & Chief Exec. Officer · Director

Sale

Date

May 20

Shares

273

Price

$20.00

Value

$5K

View Form 4 on SEC.gov

MAETZOLD DEREK J

Pres. & Chief Exec. Officer · Director

Sale

Date

May 21

Shares

880

Price

$20.20

Value

$18K

View Form 4 on SEC.gov

MAETZOLD DEREK J

Pres. & Chief Exec. Officer · Director

Option

Date

May 21

Shares

420

Price

$2.39

Value

$1K

View Form 4 on SEC.gov

MAETZOLD DEREK J

Pres. & Chief Exec. Officer · Director

Option

Date

May 20

Shares

130

Price

$2.39

Value

$311

View Form 4 on SEC.gov

MAETZOLD DEREK J

Pres. & Chief Exec. Officer · Director

Sale

Date

May 20

Shares

130

Price

$20.00

Value

$3K

View Form 4 on SEC.gov

MAETZOLD DEREK J

Pres. & Chief Exec. Officer · Director

Sale

Date

May 21

Shares

420

Price

$20.20

Value

$8K

View Form 4 on SEC.gov

MAETZOLD DEREK J

Pres. & Chief Exec. Officer · Director

Sale

Date

May 20

Shares

66

Price

$20.00

Value

$1K

View Form 4 on SEC.gov

MAETZOLD DEREK J

Pres. & Chief Exec. Officer · Director

Sale

Date

May 21

Shares

212

Price

$20.20

Value

$4K

View Form 4 on SEC.gov

MAETZOLD DEREK J

Pres. & Chief Exec. Officer · Director

Sale

Date

May 7

Shares

1,159

Price

$22.08

Value

$26K

View Form 4 on SEC.gov

MAETZOLD DEREK J

Pres. & Chief Exec. Officer · Director

Sale

Date

May 7

Shares

198

Price

$22.59

Value

$4K

View Form 4 on SEC.gov

MAETZOLD DEREK J

Pres. & Chief Exec. Officer · Director

Sale

Date

May 7

Shares

985

Price

$22.08

Value

$22K

View Form 4 on SEC.gov

MAETZOLD DEREK J

Pres. & Chief Exec. Officer · Director

Sale

Date

May 7

Shares

168

Price

$22.59

Value

$4K

View Form 4 on SEC.gov

MAETZOLD DEREK J

Pres. & Chief Exec. Officer · Director

Option

Date

May 7

Shares

6,214

Price

$2.39

Value

$15K

View Form 4 on SEC.gov

MAETZOLD DEREK J

Pres. & Chief Exec. Officer · Director

Sale

Date

May 7

Shares

5,308

Price

$22.08

Value

$117K

View Form 4 on SEC.gov

MAETZOLD DEREK J

Pres. & Chief Exec. Officer · Director

Sale

Date

May 7

Shares

906

Price

$22.59

Value

$20K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About CSTL insider trading

CSTL insider trades

Castle Biosciences, Inc. (CSTL) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including MAETZOLD DEREK J (Pres. & Chief Exec. Officer · Director), Juvenal Tobin W (Chief Commercial Officer), Cole G Bradley (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. CSTL insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Castle Biosciences, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

CSTL insider trading · 5 questions

The insiders of Castle Biosciences, Inc. (CSTL) include executives and directors such as MAETZOLD DEREK J (Pres. & Chief Exec. Officer · Director), Juvenal Tobin W (Chief Commercial Officer), Cole G Bradley (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

CSTL board member insider tradingwho are CSTL insidersCSTL insider rosterCastle Biosciences, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026